Effects of a selective endothelin A receptor antagonist, ABT-627, in healthy normotensive anaesthetized rats developing acute pulmonary air embolism

被引:5
作者
Ayach, B
Tsang, J
Jeng, AY
Blouin, A
Gosselin, M
Wang, FH
Wu-Wong, JYR
Wessale, J
Opgenorth, TJ
Battistini, B
机构
[1] Univ Laval, Dept Med, Quebec Heart & Lung Inst, Laval Hosp Res Ctr, Ste Foy, PQ G1V 4G5, Canada
[2] Univ British Columbia, Pulm Res Labs, St Pauls Hosp, Dept Med, Vancouver, BC V6Z 1Y6, Canada
[3] Novartis Pharmaceut, Novartis Inst Biomed Res, Metab & Cardiovasc Dis, Summit, NJ 07901 USA
[4] Abbott Labs, Div Pharmaceut Prod, Abbott Pk, IL 60064 USA
关键词
pulmonary; air embolism; hypertension; blood pressure; endothelin; ETA receptor; gene expression;
D O I
10.1042/CS103S371S
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Acute pulmonary air embolism (APAE) injures the vascular endothelium in the lung and results in pulmonary hypertension (PH). Endothelins (ETs), a family of potent vasoactive peptides, are known to be associated with PH of various aetiologies. We evaluated the effects of ABT-627, a selective ETA receptor (ETA-R) antagonist in a rat model of APAE over 3 h. APAE rats developed a higher right ventricular systolic pressure (RVSP), lower mean arterial blood pressure (MABP), and had lower PaO2. At 3 h, arterial plasma levels of ET-1 were increased. ABT-627-treated controls showed no effects. However, ABT-627 significantly lowered RVSP during APAE, abolished the short recovery phase (within 10-25 min) of MABP without affecting the subsequent lowering of MABP, and improved oxygen saturation in APAE rats. These results show that ETA-R subtype is involved in the pathogenesis of APAE since a blockade of this receptor subtype attenuated the cardiopulmonary deterioration and improved blood gas exchanges in rats with this disease.
引用
收藏
页码:371S / 375S
页数:5
相关论文
共 20 条
[1]   BQ123, AN ET(A)-RECEPTOR ANTAGONIST, ATTENUATES HYPOXIC PULMONARY-HYPERTENSION IN RATS [J].
BONVALLET, ST ;
ZAMORA, MR ;
HASUNUMA, K ;
SATO, K ;
HANASATO, N ;
ANDERSON, D ;
SATO, K ;
STELZNER, TJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (04) :H1327-H1331
[2]   EXPERIMENTAL PULMONARY EMBOLUS IN THE RAT - A NEW INVIVO MODEL TO TEST THROMBOLYTIC DRUGS [J].
CLOZEL, JP ;
HOLVOET, P ;
TSCHOPP, T .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 12 (05) :520-525
[3]   Coronary constriction and consequent cardiodepression in pulmonary embolism are mediated by pulmonary big endothelin and enhanced in early endothelial dysfunction [J].
Dschietzig, T ;
Laule, M ;
Alexiou, K ;
Schrör, K ;
Baumann, G ;
Stangl, K .
CRITICAL CARE MEDICINE, 1998, 26 (03) :510-517
[4]  
Dupuis, 1999, J Cardiovasc Pharmacol Ther, V4, P33, DOI 10.1177/107424849900400106
[5]   Enhanced expression of renal endothelin-converting enzyme-1 and endothelin-A-receptor mRNA in rats with interstitial fibrosis following ureter ligation [J].
Feldman, DL ;
Mogelesky, TC ;
Chou, M ;
Jeng, AY .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 :S255-S259
[6]   ENDOTHELIUM-DERIVED RELAXING AND CONTRACTING FACTORS [J].
FURCHGOTT, RF ;
VANHOUTTE, PM .
FASEB JOURNAL, 1989, 3 (09) :2007-2018
[7]   Endothelin mediates pulmonary vascular remodelling in a canine model of chronic embolic pulmonary hypertension [J].
Kim, H ;
Yung, GL ;
Marsh, JJ ;
Konopka, RG ;
Pedersen, CA ;
Chiles, PG ;
Morris, TA ;
Channick, RN .
EUROPEAN RESPIRATORY JOURNAL, 2000, 15 (04) :640-648
[8]   ENHANCED ENDOTHELIN-1 AND ENDOTHELIN RECEPTOR GENE-EXPRESSION IN CHRONIC HYPOXIA [J].
LI, HB ;
CHEN, SJ ;
CHEN, YF ;
MENG, QC ;
DURAND, J ;
OPARIL, S ;
ELTON, TS .
JOURNAL OF APPLIED PHYSIOLOGY, 1994, 77 (03) :1451-1459
[9]   Endothelin receptor blockade attenuates air embolization-induced pulmonary hypertension in sheep [J].
Miyahara, T ;
Koizumi, T ;
Kubo, K ;
Hanaoka, M ;
Kaneki, T ;
Yamamoto, H ;
Ge, RL ;
Fujimoto, K ;
Kobayashi, T ;
Shibamoto, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 385 (2-3) :163-169
[10]   Acute pulmonary embolism 1: pathophysiology, clinical presentation, and diagnosis [J].
Riedel, M .
HEART, 2001, 85 (02) :229-240